Objective We studied the dose-response effects of acute administration
of the selective A(1) adenosine receptor agonist 2-chloro-NG-cyclopen
tyladenosine (CCPA), the selective A(2A) agonists 2-hexynyl-5'-N-ethyl
carboxamidoadenosine (2HE-NECA) and hyl)phenethylamino]-5'-N-ethylcarb
oxamidoadenosine (CGS 21680) and the non-selective agonist N-ethylcarb
oxamidoadenosine (NECA) on plasma renin activity, atrial natriuretic p
eptide, cyclic guanosine 3',5'-monophospfrate (cGMP) and endothelin-l
in spontaneously hypertensive rats. Methods The drugs were administere
d intraperitoneally in four doses to conscious rats, Systolic blood pr
essure and heart: rate were measured by the tail-cuff technique. Both
humoral and hemodynamic parameters were determined Ih after dosing in
separate sets of animals. Results All the compounds induced a dose-dep
endent decrease in systolic blood pressure that was associated with di
fferent changes in heart rate, Heart rate was decreased by all doses o
f CCPA and by the higher doses of the non-selective compound (NECA) an
d increased by both AZA agonists, Plasma renin activity also changed i
n opposite directions, being decreased by CCPA increased dose-dependen
tly 2HE-NECA and 21680 and only moderately natriuretic peptide and cGM
P levels increased dose-dependently after CCPA and NECA, but were unaf
fected by the A(2A) agonists. None of the compounds altered plasma end
othelin-1 levels. Conclusions These results indicate that the renin-su
ppressive effect of the A(1) agonist, which is associated with a cardi
odepressant action, may be attributed either to a direct inhibition of
renin release or to the concomitant increments in plasma atrial natri
uretic peptide and its second messenger, cGMP. In contrast, the renin-
stimulating effect of the A(2A) agonists may result either from direct
stimulation of renin secretion or from reflex sympathetic activation
secondary to the fall in blood pressure.